Granulomatous dermatitis post Mycobacterium Indicus Pranii (MIP) vaccine in severe covid-19 infection: an exaggerated hypersensitivity phenomenon
Mycobacterium indicus pranii (MIP) vaccine is widely used in dermatology as immunotherapy for warts as well as in patients with leprosy. During the COVID-19 pandemic, a positive role of MIP as an immunomodulator in SARS-CoV-2 disease was reported after pilot research, with minor adverse effects. We...
Saved in:
Main Authors: | Pooja Agarwal, Raju Chaudhary, Kalgi Baxi, Malhar Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
Series: | Journal of the Egyptian Women’s Dermatologic Society |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jewd.jewd_41_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancing the Indian cattle pangenome: characterizing non-reference sequences in Bos indicus
by: Sarwar Azam, et al.
Published: (2025-02-01) -
Advancements in synthesis of Molecularly Imprinted Polymer (MIPs) for highly selective alcohol sensors
by: Wulan Khaerani, et al.
Published: (2025-02-01) -
Rat Model of Cystic Neutrophilic Granulomatous Mastitis by Corynebacterium Kroppenstedtii
by: Wang M, et al.
Published: (2025-02-01) -
Clinical characteristics, complications and satisfaction of megameatus intact prepuce (MIP) hypospadias variant: a 15 year retrospective study
by: Meng He, et al.
Published: (2025-01-01) -
The Autoimmune Profiles in the Etiopathogenesis of Granulomatous Lobular Mastitis
by: Lu Xie, et al.
Published: (2025-03-01)